Minimally Invasive Surgery for Cancer: Indications and Outcomes

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: closed (1 July 2022) | Viewed by 7352

Special Issue Editor


E-Mail Website
Guest Editor
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Interests: thoracic surgery

Special Issue Information

Dear Colleagues, 

The modern era of minimally invasive surgery began with the first laparoscopic cholecystectomy performed in 1987. The minimally invasive approach has since transformed nearly every subspecialty of surgery, and demand has greatly increased with advances in techniques and technology. Today, studies compare outcomes not only between open and minimally invasive operations but also between different minimally invasive approaches. Potential peri-operative benefits of minimally invasive surgery include shorter hospital stays, less pain, fewer complications, and faster recovery. In the context of surgery for cancer, long-term oncologic outcomes are also a critical measure by which the selection of surgical approach must be evaluated. In addition to curative operations, minimally invasive surgery also plays a role in the diagnosis, staging, and palliation of cancer. Areas for innovation include improvement of localization techniques, development of haptic feedback, strategies to minimize the learning curve, and reducing cost. The utilization of various minimally invasive techniques is dependent on the unique anatomic, physiologic, and oncologic requirements of specific cancer operations and patient populations, and the articles included in this Special Edition thoughtfully elucidate the indications and outcomes of minimally invasive surgery for a variety of cancer scenarios.

Dr. Jane Yanagawa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endoscopic surgery
  • thoracoscopy
  • laparoscopy
  • robotic surgery
  • minimally invasive surgery
  • staging
  • diagnosis
  • perioperative outcomes
  • oncologic outcomes
  • enhanced recovery

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 321 KiB  
Review
Outcomes of Minimally Invasive and Robot-Assisted Esophagectomy for Esophageal Cancer
by Kian C. Banks, Diana S. Hsu and Jeffrey B. Velotta
Cancers 2022, 14(15), 3667; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14153667 - 28 Jul 2022
Cited by 3 | Viewed by 1257
Abstract
With the evolution of minimally invasive esophagectomy (MIE) and robot-assisted minimally invasive esophagectomy (RAMIE), questions remain regarding the benefits and indications of these methods. Given that set indications do not exist, this article aims first to review the reported outcomes of MIE, RAMIE, [...] Read more.
With the evolution of minimally invasive esophagectomy (MIE) and robot-assisted minimally invasive esophagectomy (RAMIE), questions remain regarding the benefits and indications of these methods. Given that set indications do not exist, this article aims first to review the reported outcomes of MIE, RAMIE, and open esophagectomy. Then, considerations based on the reported outcomes are discussed to guide surgeons in selecting the best approach. MIE and RAMIE offer the potential to improve outcomes for esophagectomy patients; however, surgeon experience as well as individual patient factors play important roles when deciding upon the surgical approach. Full article
(This article belongs to the Special Issue Minimally Invasive Surgery for Cancer: Indications and Outcomes)
22 pages, 1448 KiB  
Review
Endoscopic Management of Esophageal Cancer
by Christopher Paiji and Alireza Sedarat
Cancers 2022, 14(15), 3583; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14153583 - 22 Jul 2022
Cited by 1 | Viewed by 5678
Abstract
Advances in technology and improved understanding of the pathobiology of esophageal cancer have allowed endoscopy to serve a growing role in the management of this disease. Precursor lesions can be detected using enhanced diagnostic modalities and eradicated with ablation therapy. Furthermore, evolution in [...] Read more.
Advances in technology and improved understanding of the pathobiology of esophageal cancer have allowed endoscopy to serve a growing role in the management of this disease. Precursor lesions can be detected using enhanced diagnostic modalities and eradicated with ablation therapy. Furthermore, evolution in endoscopic resection has provided larger specimens for improved diagnostic accuracy and offer potential for cure of early esophageal cancer. In patients with advanced esophageal cancer, endoluminal therapy can improve symptom burden and provide therapeutic options for complications such as leaks, perforations, and fistulas. The purpose of this review article is to highlight the role of endoscopy in the diagnosis, treatment, and palliation of esophageal cancer. Full article
(This article belongs to the Special Issue Minimally Invasive Surgery for Cancer: Indications and Outcomes)
Show Figures

Figure 1

Back to TopTop